March 14, 2023 - Leukemia

March 14, 2023
Please note, access to symposium recordings is included with registration.
Access will be available for 30 days post event.

With several new drug and cellular therapies as well as an expansion of our understanding of the biologic heterogeneity of hematologic malignancies, there is a need for ongoing education in the area of hematologic malignancies. This interactive webinar series will focus on current best practices and major updates in the biology, diagnosis, and management of hematologic malignancies.

Each 90-minute webinar will have two talks followed by 30 minutes of discussion and audience questions. Presenters will include internationally-known disease experts from Mass General Cancer Center covering practice-changing updates in cellular therapies, transplant, myeloma, leukemia, and lymphoma

Target Audience

This activity is intended for physicians, nurses, physician assistants, other members of healthcare team (regional) with specialties such as general practice, hematology, hematology/oncology, medical oncology, primary care, and radiation oncology.

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Discuss practice-changing updates in the management of AML/MDS and MPNs
  2. Identify new therapies available for AML/MDS and MPNs

Additional Information

Provided by: 

Massachusetts General Hospital Cancer Center & Mass General Brigham

Course summary
Available credit: 
  • 1.50 AAPA Category I CME
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Nursing Contact Hours
  • 1.50 Participation
Course opens: 
09/22/2022
Course expires: 
07/01/2023
Event starts: 
03/14/2023 - 5:00pm EDT
Event ends: 
03/14/2023 - 6:30pm EDT
Cost:
$45.00
Part of: 
Mass General Cancer Center Practice-Changing Updates in Hematologic Malignancies
Add to calendar: 
5:00pm

Practice Changing Updates in AML/MDS
Andrew Brunner, MD

5:30

Practice Changing Updates in MPNs
Gaby Hobbs, MD

6:00

Q&A/Discussion

6:30Adjourn

 

Course Director

P. Connor Johnson, MD
Hematology/Oncology, Massachusetts General Hospital Cancer Center
Instructor in Medicine, Harvard Medical School

Speakers

Andrew Brunner, MD
Assistant Professor of Medicine, Harvard Medical School
Massachusetts General Hospital Cancer Center

Gaby Hobbs, MD
Clinical Director, Leukemia Service, Massachusetts General Hospital Cancer Center
Assistant in Medicine, Harvard Medical School

 

In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

AMA PRA Category 1 CreditsTM
Mass General Brigham designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing
Mass General Brigham designates this activity for 1.5 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.

Physician Assistants
Mass General Brigham has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Available Credit

  • 1.50 AAPA Category I CME
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Nursing Contact Hours
  • 1.50 Participation

Price

Cost:
$45.00
Please login or register to take this course.

CANCELLATION POLICY:

Registrations cancelled on or before February 28, 2023 will be refunded, less a $15 administrative fee. Registrations cancelled after February 28, 2023 will not be refunded.

Contact partnerscpd@partners.org if you require assistance in cancelling your online registration.